The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer

被引：0
|
作者：
Emmanouil V. Dermitzakis
Vasilios K. Kimiskidis
George Lazaridis
Zoi Alexopoulou
Eleni Timotheadou
Alexandros Papanikolaou
Ourania Romanidou
George Georgiadis
Konstantine T. Kalogeras
Iakovos Tsiptsios
Basil Tarlatzis
George Fountzilas
机构：
[1] “Papageorgiou” Hospital,Laboratory of Clinical Neurophysiology, Department of Neurology
[2] Aristotle University of Thessaloniki,Laboratory of Clinical Neurophysiology
[3] Faculty of Medicine,Department of Medical Oncology, School of Health Sciences, Faculty of Medicine
[4] “Papageorgiou” Hospital,Department of Biostatistics
[5] Aristotle University of Thessaloniki,First Department of Obstetrics and Gynecology, School of Health Sciences, Faculty of Medicine
[6] Health Data Specialists Ltd,Neurological Department
[7] “Papageorgiou” Hospital,Laboratory of Molecular Oncology
[8] Aristotle University of Thessaloniki,undefined
[9] “Hippocration” General Hospital,undefined
[10] Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki,undefined
[11] Translational Research Section,undefined
[12] Hellenic Cooperative Oncology Group,undefined
[13] Data Office,undefined
来源：
BMC Neurology | / 16卷
关键词：
30/15 ratio; Autonomous nervous system; Orthostatic hypotension; Paclitaxel; Sympathetic skin response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer
    Dermitzakis, Emmanouil V.
    Kimiskidis, Vasilios K.
    Lazaridis, George
    Alexopoulou, Zoi
    Timotheadou, Eleni
    Papanikolaou, Alexandros
    Romanidou, Ourania
    Georgiadis, George
    Kalogeras, Konstantine T.
    Tsiptsios, Iakovos
    Tarlatzis, Basil
    Fountzilas, George
    BMC NEUROLOGY, 2016, 16
  • [2] Chemotherapy for ovarian cancer: Beyond paclitaxel plus carboplatin
    Ozols, RF
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1999, 5 (06): : 336 - 338
  • [3] The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and carboplatin chemotherapy
    Xia Wu
    Qin-Mei Feng
    Ying Wang
    Jun Shi
    Hai-Liang Ge
    Wen Di
    Cancer Immunology, Immunotherapy, 2010, 59 : 279 - 291
  • [4] Pharmacokinetic and pharmacodynamic analysis of combined chemotherapy with carboplatin and paclitaxel for patients with ovarian cancer
    Arakawa A.
    Nishikawa H.
    Suzumori K.
    Kato N.
    International Journal of Clinical Oncology, 2001, 6 (5) : 248 - 252
  • [5] The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and carboplatin chemotherapy
    Wu, Xia
    Feng, Qin-Mei
    Wang, Ying
    Shi, Jun
    Ge, Hai-Liang
    Di, Wen
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (02) : 279 - 291
  • [6] Sorafenib in combination with carboplatin and paclitaxel as neoadjuvant chemotherapy in patients with advanced ovarian cancer
    Martin Pölcher
    Meike Eckhardt
    Christoph Coch
    Matthias Wolfgarten
    Kirsten Kübler
    Gunther Hartmann
    Walther Kuhn
    Christian Rudlowski
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 203 - 207
  • [7] Sorafenib in combination with carboplatin and paclitaxel as neoadjuvant chemotherapy in patients with advanced ovarian cancer
    Poelcher, Martin
    Eckhardt, Meike
    Coch, Christoph
    Wolfgarten, Matthias
    Kuebler, Kirsten
    Hartmann, Gunther
    Kuhn, Walther
    Rudlowski, Christian
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (01) : 203 - 207
  • [8] Influence of paclitaxel and carboplatin on the immune system of cancer patients during chemotherapy
    Ginopoulos, PV
    Gogos, CA
    Thanopoulou, E
    Kardamakis, D
    Mastronikolis, NS
    Drosou, E
    Koukouras, D
    Zoumbos, NC
    MEDICAL SCIENCE RESEARCH, 1999, 27 (04): : 227 - 229
  • [9] Safety and Efficacy of Weekly Paclitaxel and Cisplatin Chemotherapy for Ovarian Cancer Patients with Hypersensitivity to Carboplatin
    Tate, Shinichi
    Nishikimi, Kyoko
    Matsuoka, Ayumu
    Otsuka, Satoyo
    Shozu, Makio
    CANCERS, 2021, 13 (04) : 1 - 11
  • [10] Patients with carboplatin, paclitaxel, and epirubicin combination as first-line chemotherapy in ovarian cancer
    Kristensen, GB
    Havsten, H
    Kaern, J
    Tropé, C
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 96 - 96
12345